睿智医药
(300149)
| 流通市值：50.85亿 | | | 总市值：50.94亿 |
| 流通股本：4.97亿 | | | 总股本：4.98亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 347,919,860.57 | 368,328,773.14 | 319,420,527.01 | 317,152,014.39 |
| 结算备付金 | - | 0 | - | - |
| 拆出资金 | - | 0 | - | - |
| 衍生金融资产 | - | 0 | - | - |
| 应收票据及应收账款 | 203,109,249.68 | 176,719,261.33 | 203,009,214.4 | 190,427,409.77 |
| 其中：应收票据 | 312,715 | 0 | - | - |
| 应收账款 | 202,796,534.68 | 176,719,261.33 | 203,009,214.4 | 190,427,409.77 |
| 应收款项融资 | - | 0 | - | - |
| 预付款项 | 8,290,922.07 | 7,047,438.71 | 14,856,493.04 | 12,607,728.05 |
| 应收保费 | - | 0 | - | - |
| 应收分保账款 | - | 0 | - | - |
| 应收分保合同准备金 | - | 0 | - | - |
| 其他应收款合计 | 12,385,947.41 | 12,057,751.99 | 12,618,212.71 | 11,755,470.38 |
| 存货 | 13,596,368.84 | 11,441,020.5 | 10,282,754.97 | 17,178,783.84 |
| 合同资产 | 18,017,505.03 | 22,291,678.4 | 12,713,262.58 | 6,741,245.34 |
| 一年内到期的非流动资产 | 352,219.34 | 352,719.84 | 343,838.54 | 349,697.25 |
| 其他流动资产 | 38,019,697.77 | 44,784,709.29 | 48,364,856.25 | 57,510,093.28 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 645,941,574.54 | 644,069,184.3 | 623,951,592 | 615,056,179.17 |
| 非流动资产: | | | | |
| 长期股权投资 | 216,233,441.26 | 214,462,948.08 | 203,472,804.25 | 200,483,067.36 |
| 其他非流动金融资产 | - | - | 2,296,500 | 2,296,500 |
| 投资性房地产 | 75,055,657.23 | 76,016,030.1 | 73,969,332.07 | 76,199,280.42 |
| 固定资产 | 322,499,349.21 | 333,799,821.53 | 349,468,721.41 | 355,599,248.77 |
| 在建工程 | 15,617,835.64 | 12,995,305.59 | 12,811,848.63 | 11,082,554.32 |
| 生产性生物资产 | - | 0 | - | - |
| 油气资产 | - | 0 | - | - |
| 使用权资产 | 340,605,539.98 | 337,085,730.75 | 354,250,340.43 | 430,840,575.2 |
| 无形资产 | 30,033,459.78 | 30,660,729.43 | 29,976,412.06 | 30,565,997.42 |
| 开发支出 | - | 0 | - | - |
| 商誉 | - | 0 | 139,260,380.19 | 139,260,380.19 |
| 长期待摊费用 | 257,816,907.24 | 267,093,634.58 | 282,348,456.99 | 302,883,975.02 |
| 递延所得税资产 | 43,473,192.73 | 39,458,483.05 | 39,005,506.17 | 46,314,266.71 |
| 其他非流动资产 | 39,786,200.2 | 40,166,101.85 | 45,836,633.8 | 44,266,015.33 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 1,341,121,583.27 | 1,351,738,784.96 | 1,532,696,936 | 1,639,791,860.74 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 1,987,063,157.81 | 1,995,807,969.26 | 2,156,648,528 | 2,254,848,039.91 |
| 流动负债: | | | | |
| 短期借款 | 58,468,944.44 | 58,468,944.44 | 28,454,722.22 | 38,468,888.89 |
| 应付票据及应付账款 | 46,049,995.04 | 64,024,439.39 | 47,723,120.55 | 43,471,258.9 |
| 应付账款 | 46,049,995.04 | 64,024,439.39 | 47,723,120.55 | 43,471,258.9 |
| 合同负债 | 40,354,802.77 | 39,360,686.83 | 57,451,407.44 | 55,519,373.24 |
| 应付手续费及佣金 | - | 0 | - | - |
| 应付职工薪酬 | 35,537,659.2 | 32,963,669.98 | 40,232,401.69 | 54,884,267.75 |
| 应交税费 | 12,061,437.9 | 7,628,880.64 | 4,994,324.18 | 5,203,145.94 |
| 其他应付款合计 | 69,507,005.88 | 63,473,324.91 | 101,178,995.25 | 79,980,887.8 |
| 其中:应付利息 | - | 0 | - | - |
| 应付股利 | - | 0 | - | - |
| 一年内到期的非流动负债 | 71,335,959.69 | 80,501,522.02 | 67,157,268.07 | 82,693,169.94 |
| 其他流动负债 | 430,735.58 | 276,508.34 | 34,640.18 | 243,101.3 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 333,746,540.5 | 346,697,976.55 | 347,226,879.58 | 360,464,093.76 |
| 非流动负债: | | | | |
| 长期借款 | 37,204,795.36 | 37,204,795.36 | 40,414,916 | 40,414,916 |
| 租赁负债 | 334,543,236.2 | 337,133,877.82 | 346,658,823 | 417,489,786.97 |
| 预计负债 | 5,529,436.97 | 5,470,887.68 | 5,412,958.34 | 5,355,642.41 |
| 递延收益 | 27,875,333.03 | 28,360,653.06 | 23,396,866.37 | 24,944,659.26 |
| 递延所得税负债 | 3,750,354.83 | 2,876,961.24 | 3,868,766.81 | 9,418,336.42 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 408,903,156.39 | 411,047,175.16 | 419,752,330.52 | 497,623,341.06 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 742,649,696.89 | 757,745,151.71 | 766,979,210.1 | 858,087,434.82 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 497,963,992 | 497,963,992 | 499,776,892 | 499,776,892 |
| 资本公积 | 1,205,493,828.97 | 1,205,493,828.97 | 1,229,187,219.21 | 1,229,187,219.21 |
| 减:库存股 | - | - | 25,506,290.24 | 25,506,290.24 |
| 其他综合收益 | 21,052,894.61 | 21,325,649.59 | 8,202,184.26 | 16,491,324.06 |
| 盈余公积 | 169,649,539.17 | 169,649,539.17 | 169,649,539.17 | 169,649,539.17 |
| 未分配利润 | -673,929,631.53 | -680,571,713.18 | -515,763,893.51 | -517,003,377.89 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,220,230,623.22 | 1,213,861,296.55 | 1,365,545,650.89 | 1,372,595,306.31 |
| 少数股东权益 | 24,182,837.7 | 24,201,521 | 24,123,667.01 | 24,165,298.78 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,244,413,460.92 | 1,238,062,817.55 | 1,389,669,317.9 | 1,396,760,605.09 |
| 负债和股东权益合计 | 1,987,063,157.81 | 1,995,807,969.26 | 2,156,648,528 | 2,254,848,039.91 |
| 公告日期 | 2025-04-29 | 2025-04-29 | 2024-10-30 | 2024-08-30 |
| 审计意见(境内) | | 标准无保留意见 | | |